|
|
|
|
|
by jasonlaramburu
1711 days ago
|
|
> In a frontline healthcare setting, workers are constantly in contact with infected persons, thus the difference in testing regimens is maximized. Given that asymptomatic cases are a majority of the cases, such skewed data collection process will result in significant data taint. I don’t see how this claim is supported by data. The studies referenced showed the vaccine was less effective (vs control) for frontline healthcare workers than the general population (80% vs 95%). If the data were really tainted as you claim, and there is systematic undercounting of asymptomatic breakthrough cases, we would expect the vaccine to perform as well or better in a frontline setting as it does in the general population. My point was that the parent blatantly misrepresented the results of this study to make a point supporting anti-vaxx positions. Why is this necessary? |
|
* As I mentioned, US data is not very credible because of a data collection fumble.
* There are legitimate concerns of vaccine effectiveness dropping over time: either VE is constant over time, or boosters are necessary, but not both at the same time. Note Israel is at 40% population boosted.
* Recent Canada data is the most promising with VE against Delta infection of 87-92%. The catch is that the measurement stops at 5 months. Perhaps mix & match + large interval between shots is the golden recipe!
* OTOH, UK data is significantly less rosy. Assuming we believe PHE data (VE is negative in 30+yo age group) or the corrected version (VE is <50% in most age groups), something doesn't add up.
May the winter season be light so we can hopefully put the covid crisis past us.
https://www.cbc.ca/news/health/canada-vaccine-effectiveness-...
https://assets.publishing.service.gov.uk/government/uploads/...
https://twitter.com/LGradaigh/status/1436095950561419280